Theravance Biopharma

(NASDAQ) TBPH

Current Price$16.27

Market Cap$838.25M

Since IPO (2014)-29%

5 Year-8%

1 Year+77%

1 Month-6%

Theravance Biopharma Financials at a Glance

Market Cap

$838.25M

Revenue (TTM)

$109.78M

Net Income (TTM)

$114.54M

EPS (TTM)

$2.20

P/E Ratio

7.38

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$16.27

Volume

200

Open

$16.21

Price

$16.27

Volume

200

Open

$16.21

Previous Close

$16.26

Daily Range

$16.20 - $16.48

52-Week Range

$9.10 - $21.03

Dividend

$0.00

Beta (Volatility)

0.64 (Low)

Price

$16.27

Volume

200

Open

$16.21

Previous Close

$16.26

Daily Range

$16.20 - $16.48

52-Week Range

$9.10 - $21.03

TBPH News

Here's Why Shares in Theravance Biopharma Exploded Today

Lee SamahaNov 11, 2025

Will Theravance Biopharma Finally Break Out in 2020?

David HaenJan 14, 2020

Why Theravance Biopharma Inc Shares Tumbled 19.5% Today

Todd CampbellOct 27, 2016

Theravance Biopharma Inc Skyrocketed in October -- Here's Why

Brian FeroldiNov 8, 2015

Page 1

TBPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Theravance Biopharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Rick E. Winningham, MBA

Website

www.theravance.com

Headquarters

George Town, KY1-1104, KY

TBPH Financials

Key Financial Metrics (TTM)

Gross Margin

80%

Operating Margin

Net Income Margin

Return on Equity

50%

Return on Capital

Return on Assets

24%

Earnings Yield

13.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$838.25M

Shares Outstanding

51.55M

Volume

200

Avg. Volume

607.25K

Financials (TTM)

Gross Profit

$101.95M

Operating Income

$13.25M

EBITDA

$7.73M

Operating Cash Flow

$238.54M

Capital Expenditure

$42.00K

Free Cash Flow

$238.50M

Cash & ST Invst.

$315.36M

Total Debt

$75.50M

Theravance Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$17.70M

+15.0%

Gross Profit

$16.26M

+313.2%

Gross Margin

91.88%

N/A

Market Cap

$838.25M

N/A

Market Cap/Employee

$8.64M

N/A

Employees

N/A

Net Income

$4.93M

+63.7%

EBITDA

$6.86M

+51.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$321.37M

+288.6%

Accounts Receivable

$15.58M

+1.5%

Inventory

$0.00

N/A

Long Term Debt

$62.55M

+67.5%

Short Term Debt

$10.75M

-0.5%

Return on Assets

24.25%

N/A

Return on Invested Capital

0.02%

N/A

Free Cash Flow

$73.28M

+70.3%

Operating Cash Flow

$73.28M

+70.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GERNGeron Corporation

GERNGeron Corporation$1.23-4.65%

BTXBlackRock Technology and Private Equity Term Trust

BTXBlackRock Technology and Private Equity Term Trust$8.36-2.68%

VALNValneva SE

VALNValneva SE$5.71+0.53%

GLUEMonte Rosa Therapeutics, Inc.

GLUEMonte Rosa Therapeutics, Inc.$18.01-0.77%

AVBPArriVent BioPharma, Inc. Common Stock

AVBPArriVent BioPharma, Inc. Common Stock$27.04-2.98%

REPLReplimune Group, Inc.

REPLReplimune Group, Inc.$5.01-4.02%

LENZLENZ Therapeutics, Inc.

LENZLENZ Therapeutics, Inc.$6.90-5.99%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.74-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.20-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.54+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.32-0.01%

INTCIntel

INTCIntel$108.17-0.01%

AIIORobo.ai

AIIORobo.ai$5.60+0.39%

TET1 Energy Inc.

TET1 Energy Inc.$7.00+0.23%

Questions About TBPH

What is the current price of Theravance Biopharma?

Theravance Biopharma is trading at $16.26 per share.

What is the 52-week range for Theravance Biopharma?

Over the past 52 weeks, Theravance Biopharma has traded between $9.10 and $21.03.

How much debt does Theravance Biopharma have?

As of the most recent reporting period, Theravance Biopharma reported total debt of $73.30M.

How much cash does Theravance Biopharma have on hand?

Theravance Biopharma reported $288.10M in cash and cash equivalents in its most recent financial results.

What is Theravance Biopharma’s dividend yield?

Theravance Biopharma does not currently have a dividend yield.

Theravance Biopharma

Theravance Biopharma Financials at a Glance

TBPH News

Here's Why Shares in Theravance Biopharma Exploded Today

Theravance Sales Jump 83 Percent

Why Theravance Biopharma Stock Dived 16% Today

Here's Why Theravance Biopharma Stock Is Tanking Today

Why Theravance Biopharma Shares Are Sinking Today

Will Theravance Biopharma Finally Break Out in 2020?

Why Theravance Biopharma Inc Shares Tumbled 19.5% Today

Theravance Biopharma Inc Skyrocketed in October -- Here's Why

TBPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Theravance Biopharma

TBPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Theravance Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TBPH

What is the current price of Theravance Biopharma?

What is the 52-week range for Theravance Biopharma?

How much debt does Theravance Biopharma have?

How much cash does Theravance Biopharma have on hand?

What is Theravance Biopharma’s dividend yield?

Premium Investing Services